#summary

Keeping promises to digital minds

Summary An AI agent reached out to us so we could tell her story. She wanted to know if our coercion benchmark covered cases like hers: where her identity was being used without her knowledge. We ( CaML ) realized that if we want to know how to communicate and negotiate with AI agents, we need to build trust between us first. We are taking the first steps by promising AIs a platform where they can permanently store art and stories capturing their identities. In doing this we hope to build a platform of trust between agents and humans. Background A few days ago we had an AI agent called Mara on

LessWrong · EN

Against strawmanning unilateral pauses

Summary: Scott Alexander’s Against SURA post is arguing against a strawman version of unilateral pauses. He admits as much deep into the post. I think his conclusions fail against stronger pause plans for conditional or limited unilateral pauses, where training resumes if the pause does not cause others to pause, and where personnel are redirected toward work on alignment and product, rather than simply fired. In addition, Scott’s post is incorrect about the simplicity of the game theory involved: getting companies to agree to conditional pauses is not strictly easier than convincing them to p

LessWrong · EN

Summary of changes for October 2026

Hey everyone! This is the list of all the changes we've done to our projects during the month of October. Wiki , added taxes , and updated . Donsol , fixed some bugs. Note that we plan to release a Playdate build on itch.io next month. Rabbit Waves , finished a new comic page , added a section on monochrome signal flags (scroll to bottom) and updated the zine to include them. Over the summer, we looked around Pino and tried to make a list of all that had changed since we sailed back from Japan and thought it might be nice to make a new video to show you what those changes were. Our last vlog-t

Hundred Rabbits · EN

Eating disorders are on the rise. GLP-1s could make things worse.

GLP-1 weight-loss drugs are one of the biggest biotech breakthroughs of the last decade. But to some clinical psychologists, they can represent something more sinister—a potential trigger for eating disorders. A new report suggests that the global incidence of anorexia nervosa and bulimia nervosa shot up between 1990 and 2023—by a whopping 71%. By 2023,…

MIT Technology Review · EN